Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid
Open Access
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 110 (3), 835-842
- https://doi.org/10.1016/s0022-5223(95)70118-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The platelet function defect of cardiopulmonary bypass [see comments]Blood, 1993
- Effect of tranexamic acid on platelet ADP during extracorporeal circulationAmerican Journal of Hematology, 1991
- Coagulation, fibrinolysis and bleeding after open-heart surgeryScandinavian Journal of Thoracic and Cardiovascular Surgery, 1986
- Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal CircuitsSeminars in Thrombosis and Hemostasis, 1985
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Pharmacokinetics and bioavailability of tranexamic acidEuropean Journal of Clinical Pharmacology, 1981
- Studies on the mechanism of the antifibrinolytic action of tranexamic acidBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- The Treatment of Postperfusion Bleeding Using ε-Aminocaproic Acid, Cryoprecipitate, Fresh-Frozen Plasma, and Protamine SulfateThe Annals of Thoracic Surgery, 1979
- Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation influence of ω-aminocarboxylic acidsBiochimica et Biophysica Acta (BBA) - Protein Structure, 1975
- Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteersEuropean Journal of Clinical Pharmacology, 1974